drugset / Trial / NCT00564395

Detemir: Role in Type 1 Diabetes

NCT00564395

Phase 4 Completed 18 enrolled Montefiore Medical Center
RandomizedCrossoverOpen-labelTreatment

Summary

Study of blood sugars in the children with Type 1 Diabetes Mellitus (T1DM), who are given insulin detemir and a rapid acting insulin (aspart). It is hypothesized that there is no difference in the patterns of blood sugars when detemir is given in the same syringe or in separate syringes with rapid acting insulin.

Timeline

Start
2007-08
Primary completion
2009-12
Completion
2010-05

Drugs

EvaluationDrugModalityDoseRoute
Subject insulin aspart Protein / enzyme biologic Subcutaneous
Subject insulin detemir Protein / enzyme biologic Subcutaneous